[1] Mekjavic IB, Tipton MJ, Gennser M, Eiken O. Motion sickness potentiates core cooling during immersion in humans. J Physiol 2001;535: 619-23.

[2] Nobel G. Motion sickness increases the risk of accidental hypothermia. Eur J Appl Physiol 2006; 98: 48-55.

[3] Lawther A, Griffin, MJ. A survey of the occurence of motion sickness amongst passengers at sea. Aviat Space Environ Med 1988;59: 399-406.

[4] Wiker SF, Kennedy RS, McCauley ME, Pepper RL. Susceptibility to seasickness: influence of hull design and steaming direction. Aviat Space Environ Med 1979;50: 1046-51.

[5] Golding JF. Motion sickness suscepitibilty. Auton Neurosci 2006;129: 67-75.

[6] Wertheim AH, Bos JE, Bles W. Contributions of roll and pitch to seasickness. Brain Res Bull 1998; 47: 517-24.

[7] Johnson WH, Sunahara FA, Landolt JP. Importance of the vestibular system in visually induced nausea and self-vection. J Vestib Res 1999;9: 83-7.

[8] Bles W, Bos JE, de Graaf B, Groen E, Wertheim AH. Motion sickness: only one provokative conflict? Brain Res Bull 1998;47: 481-7.

[9] Cheung B, Vaitkus P. Perspectives of electrogastrography and motion sickness. Brain Res Bull 1998; 47: 421-31.

[10] Hu S, McChesney KA, Player KA, Bahl AM, Buchanan JB, Scozzafava JE. Systematic investigation of physiological correlates of motion sickness induced by viewing an optokinetic drum. Aviat Space Environ Med 1999;70: 759-65.

[11] Koch KL. Illusory self-motion and motion sickness: a model for brain-gut interactions and nausea. Dig Dis Sci 1999; 44(8 Suppl.): 53S-7S.

[12] Sunahara FA; Farewell J; Mintz L; Johnson WH. Pharmacological interventions for motion sickness: cardiovascular effects. Aviat Space Environ Med 1987;58: 270-6.

[13] Yates BJ, Aoki M, Burchill P, Bronstein AM, Gresty MA. Cardiovascular responses elicited by linear acceleration in humans. Exp Brain Res 1999;125: 476-84.

[14] Koch KL, Summy-Lon J, Bingaman S, Sperry N, Stern RM. Vasopressin and oxytocin responses to illusory self-motion and nausea in man. J Clin Endocrinol Metab 1990;71: 1269-75

[15] Kohl RL. Beta-Endorphin and arginine vasopressin following stressful sensory stimuli in man. Avait Space Environ Med 1992; 63: 986-93.

[16] Kim MS, Chey WD, Owyang C, Hasler WL. Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrhythmias in motion sickness. Am J Physiol 1997;272: 853-62.

[17] Xu LH, Koch KL, Summy-Long J, Stern RM, Seaton RF, Harrison TS, Demers LM, Bingaman S. Hypothalamic and gastric myoelectrical responses during vection-induced nausea in healthy Chinese subjects. J Clin Endocrinol Metab 1990;71: 1269-75.

[18] Klosterhalfen S, Kellermann S, Pan F, Stockhorst U, Hall G, Enck P. Effects of ethnicity and gender on motion sickness susceptibility. Aviat Space Environ Med 2005;76: 1051-7.

[19] Grunfeld E, Gesty MA. Relationship between motion sickness, migrane and menstruation in crew members of a „round the world“ yacht race. Brain Res Bull 1998;47: 433-6.

[20] Drummond PD. Tryptophan depletion aggravates motion sickness in migraineurs. Neurology 2005;65: 620.

[21] Bos JE, Damala D, Lewis C, Ganguly A, Turan O. Susceptibility to seasickness. Ergonomics 2007;50: 890-901.

[22] Guedry FE, Rupert AR, Reschke MF. Motion sickness and development of synergy within the spatial orientation system. A hypothetical unifying concept. Brain Res Bull 1998;47: 475-80.

[23] Bowins B. Motion sickness - a negative reinforcement model. Brain Res Bull 2010;8: 7-11.

[24] Golding JF. Motion sickness susceptibility questionnaire revised and its relationship to other forms of sickness. Brain Res Bull 1998;47: 507-16.

[25] Owen N, Leadbetter AG, Yardley L. Relationship between postural control and motion sickness in healthy subjects. Brain Res Bull 1998;47: 471-4.

[26] Alley TR, Willet KA, Muth ER. Motion sickness, food neophobia and sensation seeking. Percept Mot Skills 2006;102: 683.

[27] Lawson BD, Mead AM. The sopite syndrome revisited: Drowsiness and mood changes during real or apparent motion. Acta Astronautica 1998;43: 181-92.

[28] Stoffregen TA, Smart LJ. Postural instability precedes motion sickness. Brain Res Bull 1998;47: 437-48.

[29] Dahlman J, Sjörs A, Lindström J, Ledin T, Falkmer T. Performance and Autonomic Responses During Motion Sickness. Hum Fact Erg Soc 2009;51: 56-66.

[30] Graybiel A, Wood CD, Miller EF, Cramer DB. Diagnostic criteria for grading the severity of acute motion sickness. Aerospace Med 1968;39: 453-5.

[31] Gianaros JP, Muth ER, Modkoff JT. A Questionnaire for the Assessment of the Multiple Dimensions of Motion Sickness. Aviat Space Environ Med 2001; 72: 115–9.

[32] Graybiel A, Knepton J. Sopite syndrome: a sometimes sole manifestation of motion sickness. Aviat Space Environ Med 1976;47: 873-82.

[33] Cohen H. Vertigo after sailing a 19th century ship. J Vestib Res 1996;6: 31-5.

[34] Hain TC, Hanna PA, Rheinberger MA. Mal de debarquement. Arch Otolaryngol Head Neck Surg 1999;125: 615-20.

[35] Hu S, Stritzel R, Chandler A, Stern-RM. P6-acupressure reduces symptoms of vection-induced motion sickness. Aviat-Space-Environ Med 1995;66: 631-4.

[36] Lien HC, Sun WM, Chen YH, Kim H, Hasler W, Owyang C. Effects of ginger on motion sickness and gastric slowwave dysrhythmias induced by circular vection. Am J Physiol Gastrointest Liver Physiol 2003;284: 481-9.

[37] Caillet G et al. Effect of sporting activity practice on susceptibility to motion sickness. Brain Res Bull 2006; 69:288-93

[38] Jarisch R. Histamin-Intoleranz und Seekrankheit. 2. Edition. Stuttgart, Thieme Publishing , 2004.

[39] Kousoulis P, Pantes A. Eradication of helicobacter pylori infection aids with the outcome of motion sickness adaptation. Audiol Neurootol 2010;16: 164-7.

[40] Nobel G, Tribukait A, Mekjavic IB, Eiken O. Histaminergic and cholinergic neuron systems in the impairment of human thermoregulation during motion sickness. Brain Res Bull 2010;82: 193-200.

[41] Landolt JP, Light IM, Greenen MG, Monaco C. Seasickness in totally-enclosed motor-propelled survival craft: five offshore oil rig disasters. Aviat Space Environ Med 1992;63: 138-44.

[42] Hershkovitz D, Asna N, Shupak A, Kaminski G, Bar R, Tal D. Ondansetron for the prevention of seasickness in susceptible sailors: an evaluation at sea. Aviat Space Environ Med 2009;80: 643-6.

[43] Bos JE, McKinnon SN, Patterson A. Motion sickness symptoms in a ship motion simulator: effects of inside, outside and no view. Aviat Space Environ Med 2005;76: 1111-8.

[44] Rolnick A, Lubow RE. Why ist the driver rarely motion sick? The role of controllability in motion sickness. Ergonomics 1991;34: 867-79.

[45] Wright, LD. The use of motion sickness bands to control nausea and vomiting in a group of hospice patients. Am J Hospice and Palliat Med 2005;22: 49-53.

[46] Lee A, Done ML. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev, January 1, 2004; (3): CD003281.

[47] Frey UH, Scharmann P, Löhlein C, Peters J. P6 acustimulation effectively decreases postoperative nausea and vomiting in high-risk patients. Brit J Anaesth 2009;102: 620-5.

[48] Bertalanffy P, Hoerauf K, Fleischhackl R, Strasser H, Wicke F, Greher M et al. Korean Hand Acupressure for Motion Sickness in Prehospital Trauma Care: A Prospective, Randomized, Double-Blinded Trial in a Geriatric Population. Anesth Analg 2004;98: 220-3.

[49] Nachum Z, Shupak A, Gordon CR. Transdermal scopolamine for prevention of motion sickness: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 2006;45: 543-66.

[50] Gil A, Nachum Z, Dachir S, Chapman S, Levy A, Shupak A, et al. Scopolamine patch to prevent seasickness: clinical response vs. plasma concentrations in sailors. Aviat Space Environ Med 2005;76: 766-70.

5[1] Bar R, Gil A, Tal D. Safety of double-dose transdermal scopolamine. Pharmacotherapy 2009;29: 1082-8.

[52] Simmons RG, Phillips JB, Lojewski RA, Wang Z, Boyd JL, Putcha L. The efficacy of low-dose intranasal scopolamine for motion sickness. Aviat Space Environ Med 2010; 81:405-12.

[53] Wood CD, Manno JE, Wood MJ, Manno BR, Mims ME. Comparison of efficacy of ginger with various antimotion sickness drugs. Clin Res Pr Drug Regul Aff 1988; 6: 129-36.

[54] Takeda N, Morita M, Horii A, Nishiike S, Kitahara T, Uno A. Neural mechanisms of motion sickness. J Med Invest 2001; 48: 44-59.

[55] Howland J, Rohsenow DJ, Minsky S, Snoberg J, Tagerud S, Hunt SK, et al. The effects of transdermal scopolamine on simulated ship navigation and attention/reaction time. Int J Occup Environ Health, October 1, 2008; 14(4): 250-6.

[56] Muth ER, Jokerst M, Stern RM, Koch KL. Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness. Aviat Space Environ Med 1995;66: 1041-5.

[57] See-Berufsgenossenschaft (Hrsg.): German Medical Guide for Ships. Manual for Captains and Ship's Officers. 530 Pages, incl. CD-Rom. 5. Ed. 2008, ISBN 978-3-87166-062-7.

[58] Dahl E, Offer-Ohlsen D, Lillevold PE, Sandvik L. Transdermal scopolamine, oral meclizine, and placebo in motion sickness. Clin Pharmacol Ther 1984; 36: 116-20.

[59] Cowings PS, Toscano WB, DeRoshia C, Miller NE. Promethazine as a motion sickness treatment: impact on human performance and mood states. Aviat Space Environ Med 2000; 71: 1013-22.

[60] Graybiel A, Lackner JR. Treatment of severe motion sickness with antimotion sickness drug injections. Aviat Space Environ Med 1987; 58: 773-6.

[61] Davis JR, Jennings RT, Beck BG, Bagian JP. Treatment efficacy of intramuscular promethazine for space motion sickness. Aviat Space Environ Med 1993;64: 230-3.

[62] Cheung BS, Heskin R, Hofer KD. Failure of Cetirizine and Fexofenadine to Prevent Motion Sickness. Ann Pharmacother 2003;37(2): 173.

[63] Kohl RL. Failure of metoclopramide to control emesis or nausea due to stressful angular or linear acceleration. Aviat Space Environ Med 1987; 58: 125-31.

[64] Mowrey DB, Clayson DE. Motion sickness, ginger and psychophysics. Lancet 1982;1: 655-7.

[65] Grontved A, Brask T, Kambskard J, Hentzer E. Ginger root against sea-sickness. A controlled trial on the open sea. Acta Otolaryngol 1988;105: 45-9.

[66] Abdel-Aziz H, Windeck T, Ploch M, Verspohl EJ. Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-ileum. Eur J Pharmacol 2006;530: 136-43.

[67] Huber R. Untersuchungen zur Kinetoseprophylaxe. Dissertation, Philipps University Marburg, 1990.

[68] Yates BJ, Miller AD, Lucot JB. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull 1998; 15:395-406.

[69] Hoyt RE, Lawson BD, McGee HA, Strompolis ML, McClellan MA. Modafinil as a potential motion sickness countermeasure. Aviat Space Environ Med 2009;80: 709-15.

[70] Cohen B, Dai M, Yakushin SB, Raphan T. Baclofen reduces motion sickness via velocity storage system. Prog Brain Res 2008;171: 543-53.

[71] Arznei-Telegramm. Antiemetische Therapie bei Schwangerschaftserbrechen. Arzn Telegr 2009;40: 87-9

[72] Wood CD, Stewart JJ, Wood MJ, Manno JE, Manno BR, Mims ME .Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness. Aviat Space Environ Med 1990; 61: 157-61.